万春药业（BYSI.US）股东结构 - 机构持仓、大股东与内部人士｜长桥证券

© 2026 Longbridge｜服务条款隐私政策

股东类型

公众及其他71.09%
个人与内部人士13.06%
风投/私募9.24%
机构投资者6.61%

主要股东

主要股东最新
股东
Lan HuangCo-Founder & Chair of the Board	12.87%	529.34 万	0.90%	-26.06 万	2026/03/31
Decheng Capital LLC	9.24%	380.07 万	0.18%	+0	2026/03/31
Vanguard Capital Management, LLC	1.92%	78.79 万	--	+78.79 万	2026/03/31
BlackRock, Inc.	1.64%	67.29 万	0.06%	+2.35 万	2026/06/30
Sincere Efforts Foundation Inc	1.20%	49.45 万	0.02%	+0	2026/03/31
Geode Capital Management, LLC	0.89%	36.77 万	0.02%	-7,631.00	2026/06/30
State Street Investment Management	0.56%	23.11 万	0.00%	+0	2026/06/30
Northern Trust Global Investments	0.17%	6.93 万	<0.01%	+0	2026/03/31
Jiangwen MajetiIndependent Vice Chairman	0.12%	5.09 万	<0.01%	+0	2025/02/28
Tanaka Capital Management Inc	0.06%	2.63 万	<0.01%	+0	2026/03/31
Patrick FabbioIndependent Director	0.06%	2.46 万	<0.01%	+0	2025/02/28
Meridian Wealth Management, LLC	0.04%	1.50 万	0.00%	+0	2026/06/30
Farther Finance Advisors, LLC	0.03%	1.28 万	--	+1.28 万	2026/06/30
Renaissance Technologies LLC	0.03%	1.11 万	<0.01%	+100.00	2026/03/31
Lord, Abbett & Co. LLC	0.01%	6,039.00	<0.01%	+0	2026/03/31
Vanguard Global Advisers, LLC	0.01%	4,802.00	--	+0	2026/03/31
Morgan Stanley	<0.01%	4,000.00	<0.01%	-430.00	2026/03/31
National Bank Investments Inc.	<0.01%	2,875.00	0.00%	+0	2026/06/30
Trifecta Capital Advisors, LLC	<0.01%	1,500.00	0.00%	+0	2026/06/30
Tower Research Capital Europe Limited	<0.01%	1,466.00	<0.01%	+455.00	2026/06/30